+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Empty Capsules Market by Product, Raw Material, Therapeutic Application and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 290 Pages
  • December 2021
  • Region: Global
  • Allied Market Research
  • ID: 5548376
The global empty capsules market was valued at $2,382.7 million in 2020, and is projected to reach $5,230.4 million by 2030, registering a CAGR of 8.1% from 2021 to 2030.



Capsule is defined as the solid dosage in which active pharmaceutical ingredients (API) or inert substances are enclosed in soft or hard shell. Empty capsules are mostly made of gelatin. API is available in various formulations such as powder, semisolid mass, granules, and liquid. Capsules can be administered orally and vaginally. The capsule is easier to swallow as compared to other drug delivery forms such as a tablets.

Growth of the global empty capsules market is majorly driven by alarming increase in prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and gastrointestinal diseases; rise in government initiatives to spread awareness and promote advantages of nutraceuticals products; surge in number of capsule production; rise in expenditure on human healthcare services; and rise in adoption of gelatin capsules. For instance, according to the World Health Organization (WHO), in 2020, approximately 10 million deaths were reported due to cancer, globally. Healthcare supplements such as vitamin & minerals, herbs, and fibers are advised to patients having chemotherapy and radiation procedures to avoid side effects and strengthen their immune system. Moreover, in November 2021, ACG Capsules, one of the leading pharmaceutical companies, announced the launch of “ACG loves NOTHING”, which is a global nutraceutical campaign and aimed to enhance nutraceutical production through industry leading innovation and collaboration strategy.
Rise in number of geriatric population and surge in demand for vitamin and mineral supplements drive growth of the market. Geriatric population is more vulnerable to chronic diseases and osteoarthritis disease, which surge demand for various drug therapies and vitamins& minerals for better health outcomes. This surges need for empty capsule production and is expected to propel growth of the market.

Increase in development of the pharmaceutical sector and surge in need for immunity booster supplements are major factors that drive the global empty capsules market. Moreover, increase in number of clinical studies significantly contributes toward the market growth. Clinical studies aim to evaluate safety and efficacy of drugs enclosed in capsule. Rise in number of capsule manufacturing acts as a key driving force for expansion of the global market. For instance, Lonza, a multinational chemical and biotechnology company produced 230 billion capsules in 2020. Furthermore, rise in funds by government and private organizations to develop capsule manufacturing units are expected to boost the market growth. For instance, in November 2021, ACG, announced that it will invest $78.00 million (Rs 600 crore) to develop Asia’s largest capsule manufacturing unit in Maharashtra, India.

In addition, advancements in R&D activities in capsule drug delivery technology and rise in business expansion and partnership strategy are anticipated to provide lucrative opportunities for the market expansion. Moreover, in October 2020, Lonza, a multinational chemical and biotechnology company, announced the investment of $93 million in the capsule and health ingredients, which enable companies to expand its overall manufacturing capacity of capsule by 30 billion capsules, per year.

However, high cost of gelatin and lower availability of raw materials to manufacture gelatin are anticipated to hinder the market growth. On the contrary, rise in number of capsule manufacturing units, advancements of technology for development of wide range of range having different flavor, color &size, and increase in awareness among population about nutraceutical products augment growth of the empty capsules sector. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities in the empty capsules market.

The global empty capsules market is segmented into product, raw material, therapeutic application, end user, and region. By product, the market is categorized into gelatin capsules and non-gelatin capsules. The gelatin capsules segment is further divided into hard gelatin capsules (HGC) and soft gelatin capsules (SGC). On the basis of raw material, it is categorized into pig meat, bovine meat, bone, hydroxypropyl methylcellulose (HPMC), and others.

Depending on therapeutic application, it is fragmented into antibiotic & antibacterial drugs, vitamin & dietary supplements, antacids & anti-flatulent preparations, cardiac therapy drugs, and others. Depending on end user, it is fragmented into pharmaceutical manufacturers, nutraceutical manufacturers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global empty capsules market are ACG Worldwide, Bright Pharma Caps Inc., CapsCanada Corporation, Lonza Group Ltd. (Capsugel), Medi-Caps Ltd., Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), Roxlor LLC, Snail Pharma Industry Co. Ltd, Suheung Co., Ltd, and Sunil Healthcare Ltd.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the global empty capsules market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global empty capsules market.

KEY MARKET SEGMENTS


By Product

  • Gelatin Capsules
  • Non-Gelatin Capsules

By Raw Material

  • Pig Meat
  • Bovine Meat
  • Bone
  • Hydroxypropyl Methylcellulose (HPMC)
  • Others

By Therapeutic Application

  • Antibiotic & Antibacterial Drugs
  • Vitamin & Dietary Supplements
  • Antacids & Anti-Flatulent Preparations
  • Cardiac Therapy Drugs
  • Others

By End User

  • Pharmaceutical Manufacturers
  • Nutraceutical Manufacturers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • ACG Worldwide
  • Bright Pharma Caps Inc.
  • CapsCanada Corporation
  • Lonza Group Ltd. (Capsugel)
  • Medi-Caps Ltd.
  • Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
  • Roxlor LLC
  • Snail Pharma Industry Co. Ltd
  • Suheung Co., Ltd
  • Sunil Healthcare Ltd.
Frequently Asked Questions about the Global Empty Capsules Market

What is the estimated value of the Global Empty Capsules Market?

The Global Empty Capsules Market was estimated to be valued at $2382.7 million in 2020.

What is the growth rate of the Global Empty Capsules Market?

The growth rate of the Global Empty Capsules Market is 8.2%, with an estimated value of $5230.4 million by 2030.

What is the forecasted size of the Global Empty Capsules Market?

The Global Empty Capsules Market is estimated to be worth $5230.4 million by 2030.

Who are the key companies in the Global Empty Capsules Market?

Key companies in the Global Empty Capsules Market include ACG Worldwide, Bright Pharma Caps Inc., CapsCanada Corporation, Lonza Group Ltd. (Capsugel), Medi, Caps Ltd., Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), Roxlor LLCSnail Pharma Industry Co. Ltd and Sunil Healthcare Ltd..

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in prevalence of chronic diseases
3.5.1.2. Increase in number of empty capsules production
3.5.1.3. Advancements in technology to develop capsules
3.5.2. Restraints
3.5.2.1. Ethical concerns along with price fluctuations regarding gelatin material
3.5.2.2. Stringent regulations in the pharmaceutical industry
3.5.3. Opportunities
3.5.3.1. Development of pharmaceutical industry and rise in healthcare expenditure
3.5.4. Impact analysis
3.6. Impact analysis of COVID-19 on the empty capsules market
CHAPTER 4: EMPTY CAPSULE MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Gelatin capsules
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Gelatin Capsule, by Type
4.2.2.1. Market size and forecast
4.2.2.2. Hard gelatin capsule (HGC)
4.2.2.2.1. Market size and forecast
4.2.2.3. Soft gelatin capsule (SGC)
4.2.2.3.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Non-gelatin capsules
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
CHAPTER 5: EMPTY CAPSULE MARKET, BY RAW MATERIAL
5.1. Overview
5.1.1. Market size and forecast
5.2. Pig Meat
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Bovine meat
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
5.4. Bone
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country
5.5. Hydroxypropyl methylcellulose (HPMC)
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market analysis, by country
5.6. Others
5.6.1. Key market trends, growth factors, and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market analysis, by country
CHAPTER 6: EMPTY CAPSULE MARKET, BY THERAPEUTIC APPILICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Antibiotic & Antibacterial Drugs
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. Vitamin & dietary supplements
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. Antacids & anti-flatulent preparations
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
6.5. Cardiac therapy drugs
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market analysis, by country
6.6. Others
6.6.1. Key market trends, growth factors, and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market analysis, by country
CHAPTER 7: EMPTY CAPSULE MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Pharmaceutical manufacturers
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market analysis, by country
7.3. Nutraceutical manufacturers
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market analysis, by country
7.4. Others
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market analysis, by country
CHAPTER 8: EMPTY CAPSULE MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. North America emptycapsule market, by product
8.2.3. North America empty capsule market, by raw material
8.2.4. North America emptycapsule market, by therapeutic application
8.2.5. North America emptycapsule market, by end user
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. U.S. empty capsule market, by product
8.2.6.1.2. U.S. empty capsule market, by raw material
8.2.6.1.3. U.S. empty capsule market, by therapeutic application
8.2.6.1.4. U.S. empty capsule market, by end user
8.2.6.2. Canada
8.2.6.2.1. Canada empty capsule market, by product
8.2.6.2.2. Canada empty capsule market, by raw material
8.2.6.2.3. Canada empty capsule market, by therapeutic application
8.2.6.2.4. Canada empty capsule market, by end user
8.2.6.3. Mexico
8.2.6.3.1. Mexico empty capsule market, by product
8.2.6.3.2. Mexico empty capsule market, by raw material
8.2.6.3.3. Mexico empty capsule market, by therapeutic application
8.2.6.3.4. Mexico empty capsule market, by end user
8.3. Europe
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Europe empty capsule market, by product
8.3.3. Europe empty capsule market, by raw material
8.3.4. Europe empty capsule market, by therapeutic application
8.3.5. Europe empty capsule market, by end user
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Germany empty capsule market, by product
8.3.6.1.2. Germany empty capsule market, by raw material
8.3.6.1.3. Germany empty capsule market, by therapeutic application
8.3.6.1.4. Germany empty capsule market, by end user
8.3.6.2. France
8.3.6.2.1. France empty capsule market, by product
8.3.6.2.2. France empty capsule market, by raw material
8.3.6.2.3. France empty capsule market, by therapeutic application
8.3.6.2.4. France empty capsule market, by end user
8.3.6.3. UK
8.3.6.3.1. UK empty capsule market, by product
8.3.6.3.2. UK empty capsule market, by raw material
8.3.6.3.3. UK empty capsule market, by therapeutic application
8.3.6.3.4. UK empty capsule market, by end user
8.3.6.4. Italy
8.3.6.4.1. Italy empty capsule market, by product
8.3.6.4.2. Italy empty capsule market, by raw material
8.3.6.4.3. Italy empty capsule market, by therapeutic application
8.3.6.4.4. Italy empty capsule market, by end user
8.3.6.5. Spain
8.3.6.5.1. Spain empty capsule market, by product
8.3.6.5.2. Spain empty capsule market, by raw material
8.3.6.5.3. Spain empty capsule market, by therapeutic application
8.3.6.5.4. Spain empty capsule market, by end user
8.3.6.6. Rest of Europe
8.3.6.6.1. Rest of Europe empty capsule market, by product
8.3.6.6.2. Rest of Europe empty capsule market, by raw material
8.3.6.6.3. Rest of Europe empty capsule market, by therapeutic application
8.3.6.6.4. Rest of Europe empty capsule market, by end user
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Asia-Pacific empty capsule market, by product
8.4.3. Asia-Pacific empty capsule market, by raw material
8.4.4. Asia-Pacific empty capsule market, by therapeutic application
8.4.5. Asia-Pacific empty capsule market, by end user
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Japan empty capsule market, by product
8.4.6.1.2. Japan empty capsule market, by raw material
8.4.6.1.3. Japan empty capsule market, by therapeutic application
8.4.6.1.4. Japan empty capsule market, by end user
8.4.6.2. China
8.4.6.2.1. China empty capsule market, by product
8.4.6.2.2. China empty capsule market, by raw material
8.4.6.2.3. China empty capsule market, by therapeutic application
8.4.6.2.4. China empty capsule market, by end user
8.4.6.3. Australia
8.4.6.3.1. Australia emptycapsule market, by product
8.4.6.3.2. Australia empty capsule market, by raw material
8.4.6.3.3. Australia empty capsule market, by therapeutic application
8.4.6.3.4. Australia empty capsule market, by end user
8.4.6.4. India
8.4.6.4.1. India empty capsule market, by product
8.4.6.4.2. India empty capsule market, by raw material
8.4.6.4.3. India empty capsule market, by therapeutic application
8.4.6.4.4. India empty capsule market, by end user
8.4.6.5. South Korea
8.4.6.5.1. South Korea empty capsule market, by product
8.4.6.5.2. South Korea empty capsule market, by raw material
8.4.6.5.3. South Korea empty capsule market, by therapeutic application
8.4.6.5.4. South Korea empty capsule market, by end user
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Rest of Asia-Pacific empty capsule market, by product
8.4.6.6.2. Rest of Asia-Pacific empty capsule market, by raw material
8.4.6.6.3. Rest of Asia-Pacific empty capsule market, by therapeutic application
8.4.6.6.4. Rest of Asia-Pacific empty capsule market, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. LAMEA empty capsule market, by product
8.5.3. LAMEA empty capsule market, by raw material
8.5.4. LAMEA empty capsule market, by therapeutic application
8.5.5. LAMEA empty capsule market, by end user
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Brazil empty capsule market, by product
8.5.6.1.2. Brazil empty capsule market, by raw material
8.5.6.1.3. Brazil empty capsule market, by therapeutic application
8.5.6.1.4. Brazil empty capsule market, by end user
8.5.6.2. Saudi Arabia
8.5.6.2.1. Saudi Arabia empty capsule market, by product
8.5.6.2.2. Saudi Arabia empty capsule market, by raw material
8.5.6.2.3. Saudi Arabia empty capsule market, by therapeutic application
8.5.6.2.4. Saudi Arabia empty capsule market, by end user
8.5.6.3. South Africa
8.5.6.3.1. South Africa emptycapsule market, by product
8.5.6.3.2. South Africa empty capsule market, by raw material
8.5.6.3.3. South Africa empty capsule market, by therapeutic application
8.5.6.3.4. South Africa empty capsule market, by end user
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Rest of LAMEA empty capsule market, by product
8.5.6.4.2. Rest of LAMEA empty capsule market, by raw material
8.5.6.4.3. Rest of LAMEA empty capsule market, by therapeutic application
8.5.6.4.4. Rest of LAMEA empty capsule market, by end user
CHAPTER 9: COMPANY PROFILES
9.1. ACG Worldwide
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.2. Bright Pharma Caps Inc.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Product portfolio
9.3. CapsCanada Corporation
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Product portfolio
9.4. Lonza Group Ltd. (Capsugel)
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. Medi-Caps Limited
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. Roxlor LLC
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.8. Snail Pharma Industry Co. Ltd.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.9. Suheung Co., Ltd.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Product portfolio
9.10. Sunil Healthcare Ltd.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
List of Tables
TABLE 01. EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 02. GELATIN CAPSULE MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 03. GELATIN CAPSULE MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04. NON-GELATIN CAPSULE MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05. EMPTY CAPSULE MARKET, BY RAWMATERIAL, 2020-2030 ($MILLION)
TABLE 06. EMPTY CAPSULE MARKET FOR PIG MEAT, BY REGION, 2020-2030 ($MILLION)
TABLE 07. EMPTY CAPSULE MARKET FORBOVINE MEAT, BY REGION, 2020-2030 ($MILLION)
TABLE 08. EMPTY CAPSULE MARKET FORBONE, BY REGION, 2020-2030 ($MILLION)
TABLE 09. EMPTY CAPSULE MARKET FORHYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2020-2030 ($MILLION)
TABLE 10. EMPTY CAPSULE MARKET FOROTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 11. EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 12. EMPTY CAPSULE MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY REGION, 2020-2030 ($MILLION)
TABLE 13. EMPTY CAPSULE MARKET FOR VITAMIN & DIETARY SUPPLEMENTS, BY REGION, 2020-2030 ($MILLION)
TABLE 14. EMPTY CAPSULE MARKET FOR ANTACIDS & ANTI-FLATULENT PREPARATIONS, BY REGION, 2020-2030 ($MILLION)
TABLE 15. EMPTY CAPSULE MARKET FOR CARDIAC THERAPY DRUGS, BY REGION, 2020-2030 ($MILLION)
TABLE 16. EMPTY CAPSULE MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 17. EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 18. EMPTY CAPSULE MARKET FOR PHARMACEUTICAL MANUFACTURERS, BY REGION, 2020-2030 ($MILLION)
TABLE 19. EMPTY CAPSULE MARKET FOR NUTRACEUTICAL MANUFACTURERS, BY REGION, 2020-2030 ($MILLION)
TABLE 20. EMPTY CAPSULE MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 21. EMPTY CAPSULE MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 22. NORTH AMERICA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 23. NORTH AMERICA EMPTYCAPSULE MARKET, BY RAW MATERIAL, 2020-2030 ($MILLION)
TABLE 24. NORTH AMERICA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 25. NORTH AMERICA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 26. NORTH AMERICA EMPTYCAPSULE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 27. U.S. EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 28. U.S. EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 29. U.S. EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 30. U.S. EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31. CANADA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 32. CANADA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 33. CANADA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 34. CANADA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35. MEXICO EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 36. MEXICOEMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 37. MEXICO EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 38. MEXICO EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 39. EUROPE EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 40. EUROPE EMPTY CAPSULE MARKET, BY RAW MATERIAL, 2020-2030 ($MILLION)
TABLE 41. EUROPE EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 42. EUROPE EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 43. EUROPE EMPTY CAPSULE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 44. GERMANY EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 45. GERMANY EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 46. GERMANY EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 47. GERMANY EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48. FRANCE EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 49. FRANCE EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 50. FRANCE EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 51. FRANCE EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 52. UK EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 53. UK EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 54. UK EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 55. UK EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 56. ITALY EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 57. ITALY EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 58. ITALYEMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 59. ITALY EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60. SPAIN EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 61. SPAIN EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 62. SPAIN EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 63. SPAIN EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 64. REST OF EUROPE EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 65. REST OF EUROPE EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 66. REST OF EUROPE EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 67. REST OF EUROPE EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 68. ASIA-PACIFIC EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 69. ASIA-PACIFIC EMPTY CAPSULE MARKET, BY RAW MATERIAL, 2020-2030 ($MILLION)
TABLE 70. ASIA-PACIFIC EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 71. ASIA-PACIFIC EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 72. ASIA-PACIFIC EMPTY CAPSULE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 73. JAPAN EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 74. JAPAN EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 75. JAPAN EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 76. JAPAN EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 77. CHINA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 78. CHINA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 79. CHINA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 80. CHINA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 81. AUSTRALIA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 82. AUSTRALIA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 83. AUSTRALIA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 84. AUSTRALIA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85. INDIA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 86. INDIA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 87. INDIA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 88. INDIA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 89. SOUTH KOREA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 90. SOUTH KOREA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 91. SOUTH KOREA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 92. SOUTH KOREA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 93. REST OF ASIA-PACIFIC EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 94. REST OF ASIA-PACIFIC EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 95. REST OF ASIA-PACIFIC EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 96. REST OF ASIA-PACIFIC EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 97. LAMEA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 98. LAMEA EMPTY CAPSULE MARKET, BY RAW MATERIAL, 2020-2030 ($MILLION)
TABLE 99. LAMEA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 100. LAMEA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 101. LAMEA EMPTY CAPSULE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 102. BRAZIL EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 103. BRAZIL EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 104. BRAZIL EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 105. BRAZIL EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 106. SAUDI ARABIA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 107. SAUDI ARABIA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 108. SAUDI ARABIA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 109. SAUDI ARABIA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 110. SOUTH AFRICA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 111. SOUTH AFRICA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 112. SOUTH AFRICA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 113. SOUTH AFRICAEMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 114. REST OF LAMEA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 115. REST OF LAMEA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
TABLE 116. REST OF LAMEA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
TABLE 117. REST OF LAMEA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 118. ACG: COMPANY SNAPSHOT
TABLE 119. ACG: PRODUCT SEGMENTS
TABLE 120. ACG: PRODUCT PORTFOLIO
TABLE 121. BRIGHT PHARMACAPS: COMPANY SNAPSHOT
TABLE 122. BRIGHT PHARMACAPS: PRODUCT PORTFOLIO
TABLE 123. CAPSCANADA: COMPANY SNAPSHOT
TABLE 124. CAPSCANADA: PRODUCT PORTFOLIO
TABLE 125. LONZA GROUP: COMPANY SNAPSHOT
TABLE 126. LONZA GROUP: OPERATING SEGMENTS
TABLE 127. LONZA GROUP: PRODUCT PORTFOLIO
TABLE 128. LONZA GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 129. MEDI-CAPS: COMPANY SNAPSHOT
TABLE 130. MEDI-CAPS: OPERATING SEGMENTS
TABLE 131. MEDI-CAPS: PRODUCT PORTFOLIO
TABLE 132. MITSUBISHI CHEMICAL: COMPANY SNAPSHOT
TABLE 133. MITSUBISHI CHEMICAL: OPERATING SEGMENTS
TABLE 134. MITSUBISHI CHEMICAL: PRODUCT PORTFOLIO
TABLE 135. MITSUBISHI CHEMICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 136. ROXLOR: COMPANY SNAPSHOT
TABLE 137. ROXLOR: PRODUCT SEGMENTS
TABLE 138. ROXLOR: PRODUCT PORTFOLIO
TABLE 139. SNAIL PHARMA INDUSTRY: COMPANY SNAPSHOT
TABLE 140. SNAIL PHARMA INDUSTRY: PRODUCT SEGMENTS
TABLE 141. SNAIL PHARMA INDUSTRY: PRODUCT PORTFOLIO
TABLE 142. SUHEUNG CAPSULE: COMPANY SNAPSHOT
TABLE 143. SUHEUNG CAPSULE: PRODUCT PORTFOLIO
TABLE 144. SUNIL HEALTHCARE: COMPANY SNAPSHOT
TABLE 145. SUNIL HEALTHCARE: OPERATING SEGMENTS
TABLE 146. SUNIL HEALTHCARE: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. EMPTY CAPSULES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2019-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. GELATIN CAPSULE MARKET, FOR HARD GELATIN CAPSULE (HGC), 2020-2030 ($MILLION)
FIGURE 14. GELATIN CAPSULE MARKET, FOR SOFT GELATIN CAPSULE (SGC)., 2020-2030 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF GELATIN CAPSULE MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF NON-GELATIN CAPSULE MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR PIG MEAT, BY COUNTRY, 2020-2030 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR BOVINE MEAT, BY COUNTRY, 2020-2030 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR BONE, BY COUNTRY, 2020-2030 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY COUNTRY, 2020-2030 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
FIGURE 22. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2020-2030 (%)
FIGURE 23. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR VITAMIN & DIETARY SUPPLEMENTS, BY COUNTRY, 2020-2030 (%)
FIGURE 24. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR ANTACIDS & ANTI-FLATULENT PREPARATIONS, BY COUNTRY, 2020-2030 (%)
FIGURE 25. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR CARDIAC THERAPY DRUGS, BY COUNTRY, 2020-2030 (%)
FIGURE 26. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
FIGURE 27. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2020-2030 (%)
FIGURE 28. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR NUTRACEUTICAL MANUFACTURERS, BY COUNTRY, 2020-2030 (%)
FIGURE 29. COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
FIGURE 30. LONZA GROUP: NET SALES, 2018-2020 ($MILLION)
FIGURE 31. LONZA GROUP: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32. LONZA GROUP: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
FIGURE 33. MEDI-CAPS: NET SALES, 2018-2020 ($MILLION)
FIGURE 34. MITSUBISHI CHEMICAL: NET SALES, 2018-2020 ($MILLION)
FIGURE 35. MITSUBISHI CHEMICAL: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36. MITSUBISHI CHEMICAL: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
FIGURE 37. SUNIL HEALTHCARE: NET SALES, 2018-2020 ($MILLION)
FIGURE 38. SUNIL HEALTHCARE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39. SUNIL HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2020 (%)

Companies Mentioned

  • ACG Worldwide
  • Bright Pharma Caps Inc.
  • CapsCanada Corporation
  • Lonza Group Ltd. (Capsugel)
  • Medi-Caps Ltd.
  • Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
  • Roxlor LLCSnail Pharma Industry Co. Ltd
  • Suheung Co., Ltd
  • Sunil Healthcare Ltd.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...